CareDx Inc banner

CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 18.74 USD -0.11% Market Closed
Market Cap: $963.8m

Relative Value

The Relative Value of one CDNA stock under the Base Case scenario is hidden USD. Compared to the current market price of 18.74 USD, CareDx Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CDNA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

CDNA Competitors Multiples
CareDx Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
CareDx Inc
NASDAQ:CDNA
955.2m USD 2.5 -44.7 -77.3 -31
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 690 872.8 -160 127.7 -194 446.1 -192 227.3
US
Abbvie Inc
NYSE:ABBV
412.7B USD 6.7 98.6 16.1 22.4
US
Amgen Inc
NASDAQ:AMGN
206.6B USD 5.6 26.8 15.3 15.3
US
Gilead Sciences Inc
NASDAQ:GILD
186.2B USD 6.3 21.9 13.6 16.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD 10.3 31.3 23.7 24.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 091 -533.6 -581 -565.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.1B USD 5.8 18.5 14 15.9
AU
CSL Ltd
ASX:CSL
70.6B AUD 3.2 35.6 11.7 14.7
NL
argenx SE
XBRU:ARGX
39.8B EUR 11.3 36.3 39.6 40.4
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.8 -66.6 -60.1
P/S Multiple
Revenue Growth P/S to Growth
US
CareDx Inc
NASDAQ:CDNA
Average P/S: 3 063 003.3
2.5
13%
0.2
FR
Pharnext SCA
OTC:PNEXF
33 690 872.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.6
3%
1.9
US
Gilead Sciences Inc
NASDAQ:GILD
6.3
5%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.3
11%
0.9
US
E
Epizyme Inc
F:EPE
2 091
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
10%
0.6
AU
CSL Ltd
ASX:CSL
3.2
4%
0.8
NL
argenx SE
XBRU:ARGX
11.3
28%
0.4
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
P/E Multiple
Earnings Growth PEG
US
CareDx Inc
NASDAQ:CDNA
Average P/E: 38.4
Negative Multiple: -44.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
98.6
96%
1
US
Amgen Inc
NASDAQ:AMGN
26.8
18%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
21.9
14%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.3
17%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
13%
1.4
AU
CSL Ltd
ASX:CSL
35.6
11%
3.2
NL
argenx SE
XBRU:ARGX
36.3
35%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
CareDx Inc
NASDAQ:CDNA
Average EV/EBITDA: 19.1
Negative Multiple: -77.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 446.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
12%
1.3
US
Amgen Inc
NASDAQ:AMGN
15.3
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
9%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.7
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14
18%
0.8
AU
CSL Ltd
ASX:CSL
11.7
7%
1.7
NL
argenx SE
XBRU:ARGX
39.6
49%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
CareDx Inc
NASDAQ:CDNA
Average EV/EBIT: 21.5
Negative Multiple: -31
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 227.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
24%
0.9
US
Amgen Inc
NASDAQ:AMGN
15.3
3%
5.1
US
Gilead Sciences Inc
NASDAQ:GILD
16.8
13%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.7
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
23%
0.7
AU
CSL Ltd
ASX:CSL
14.7
10%
1.5
NL
argenx SE
XBRU:ARGX
40.4
56%
0.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett